Literature DB >> 23000121

Conjugation of Y. pestis F1-antigen to gold nanoparticles improves immunogenicity.

A E Gregory1, E D Williamson, J L Prior, W A Butcher, I J Thompson, A M Shaw, R W Titball.   

Abstract

The efficacy of 15 nm gold nanoparticles (AuNP) coated with Yersinia pestis F1-antigen, as an immunogen in mice, has been assessed. The nanoparticles were decorated with F1-antigen using N-hydroxysuccinimide and N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride coupling chemistry. Mice given AuNP-F1 in alhydrogel generated the greatest IgG antibody response to F1-antigen when compared with mice given AuNP-F1 in PBS or given unconjugated F1-antigen in PBS or alhydrogel. Compared with unconjugated F1-antigen, the IgG2a response was enhanced in mice dosed with AuNP-F1 in PBS (p<0.05) but not in mice immunised with AuNP-F1 in alhydrogel. All treatment groups developed a memory response to F1-antigen, the polarity of which was inflenced by formulation in alhydrogel. The sera raised against F1-antigen coupled to AuNPs was able to competitively bind to rF1-antigen, displacing protective macaque sera.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23000121      PMCID: PMC3488157          DOI: 10.1016/j.vaccine.2012.09.021

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  46 in total

1.  Effects of soil pH, temperature and water content on the growth of Burkholderia pseudomallei.

Authors:  Y S Chen; S C Chen; C M Kao; Y L Chen
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

2.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells.

Authors:  B Devika Chithrani; Arezou A Ghazani; Warren C W Chan
Journal:  Nano Lett       Date:  2006-04       Impact factor: 11.189

3.  Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague.

Authors:  E D Williamson; P J Packer; E L Waters; A J Simpson; D Dyer; J Hartings; N Twenhafel; M L M Pitt
Journal:  Vaccine       Date:  2011-05-12       Impact factor: 3.641

4.  An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model.

Authors:  E D Williamson; P M Vesey; K J Gillhespy; S M Eley; M Green; R W Titball
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

5.  Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines.

Authors:  Lauriane E Quenee; Nancy A Ciletti; Derek Elli; Timothy M Hermanas; Olaf Schneewind
Journal:  Vaccine       Date:  2011-07-16       Impact factor: 3.641

6.  Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only.

Authors:  Sandra L Giannini; Emmanuel Hanon; Philippe Moris; Marcelle Van Mechelen; Sandra Morel; Francis Dessy; Marc A Fourneau; Brigitte Colau; Joann Suzich; Genevieve Losonksy; Marie-Thérèse Martin; Gary Dubin; Martine A Wettendorff
Journal:  Vaccine       Date:  2006-06-19       Impact factor: 3.641

7.  Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice.

Authors:  W J Simpson; R E Thomas; T G Schwan
Journal:  Am J Trop Med Hyg       Date:  1990-10       Impact factor: 2.345

8.  Macromolecular organisation of recombinant Yersinia pestis F1 antigen and the effect of structure on immunogenicity.

Authors:  J Miller; E D Williamson; J H Lakey; M J Pearce; S M Jones; R W Titball
Journal:  FEMS Immunol Med Microbiol       Date:  1998-07

Review 9.  Terrorism from a public health perspective.

Authors:  R Gregory Evans; James M Crutcher; Brooke Shadel; Bruce Clements; Michael S Bronze
Journal:  Am J Med Sci       Date:  2002-06       Impact factor: 2.378

10.  Modulation of innate and adaptive immunity by biodegradable nanoparticles.

Authors:  Tomofumi Uto; Takami Akagi; Takayuki Hamasaki; Mitsuru Akashi; Masanori Baba
Journal:  Immunol Lett       Date:  2009-06-06       Impact factor: 3.685

View more
  24 in total

Review 1.  Applications and perspectives of nanomaterials in novel vaccine development.

Authors:  Yingbin Shen; Tianyao Hao; Shiyi Ou; Churan Hu; Long Chen
Journal:  Medchemcomm       Date:  2017-10-17       Impact factor: 3.597

2.  Electrically Oscillating Plasmonic Nanoparticles for Enhanced DNA Vaccination against Hepatitis C Virus.

Authors:  Mohamed Shehata Draz; Ying-Jie Wang; Frank Fanqing Chen; Yuhong Xu; Hadi Shafiee
Journal:  Adv Funct Mater       Date:  2016-12-14       Impact factor: 18.808

Review 3.  Plague Vaccines: Status and Future.

Authors:  Wei Sun
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 4.  Nanomedicine based approaches for combating viral infections.

Authors:  Saurabh Shah; Mahavir Bhupal Chougule; Arun K Kotha; Rama Kashikar; Chandraiah Godugu; Rajeev Singh Raghuvanshi; Shashi Bala Singh; Saurabh Srivastava
Journal:  J Control Release       Date:  2021-08-08       Impact factor: 11.467

Review 5.  Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria.

Authors:  Anke Osterloh
Journal:  Vaccines (Basel)       Date:  2022-05-10

Review 6.  Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens.

Authors:  Yuchen Fan; James J Moon
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-04-01

7.  Gold nanoparticles conjugating recombinant influenza hemagglutinin trimers and flagellin enhanced mucosal cellular immunity.

Authors:  Chao Wang; Wandi Zhu; Yuan Luo; Bao-Zhong Wang
Journal:  Nanomedicine       Date:  2018-04-09       Impact factor: 5.307

Review 8.  Vaccine technologies: From whole organisms to rationally designed protein assemblies.

Authors:  Christopher P Karch; Peter Burkhard
Journal:  Biochem Pharmacol       Date:  2016-05-06       Impact factor: 5.858

Review 9.  Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications.

Authors:  Christopher D Spicer; Coline Jumeaux; Bakul Gupta; Molly M Stevens
Journal:  Chem Soc Rev       Date:  2018-05-21       Impact factor: 54.564

Review 10.  Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines.

Authors:  Lantian Lu; Viet Tram Duong; Ahmed O Shalash; Mariusz Skwarczynski; Istvan Toth
Journal:  Vaccines (Basel)       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.